Stegagno Peter 4

4 · SANUWAVE Health, Inc. · Filed Apr 7, 2025

Insider Transaction Report

Form 4

Period: 2017-12-14

SANUWAVE Health, Inc.SNWV

Stegagno Peter

Chief Operating Officer

Transactions

Disposition to Issuer
Class N Warrant (right to buy)
2019-01-23−885→ 0 total
Exercise: $0.00From: 2017-12-21Exp: 2019-03-17→ Common Stock (885 underlying)
Award
Stock Option (right to buy)
2016-06-16+1,333→ 1,333 total
Exercise: $15.00Exp: 2026-06-16→ Common Stock (1,333 underlying)
Award
Stock Option (right to buy)
2016-11-09+1,132→ 1,132 total
Exercise: $67.50Exp: 2026-11-09→ Common Stock (1,132 underlying)
Award
Stock Option (right to buy)
2017-06-15+1,600→ 1,600 total
Exercise: $41.25Exp: 2027-06-15→ Common Stock (1,600 underlying)
Award
Stock Option (right to buy)
2018-09-20+2,000→ 2,000 total
Exercise: $78.75Exp: 2028-09-20→ Common Stock (2,000 underlying)
Award
Class N Warrant (right to buy)
2019-05-31+885→ 885 total
Exercise: $0.00From: 2019-05-31Exp: 2019-09-03→ Common Stock (885 underlying)
Exercise/Conversion
Class O Warrant (right to buy)
2019-08-29−1,141→ 0 total
Exercise: $0.00From: 2019-05-31Exp: 2019-09-03→ Common Stock (1,141 underlying)
Award
Stock Option (right to buy)
2024-10-22+40,000→ 40,000 total
Exercise: $14.20Exp: 2034-10-22→ Common Stock (40,000 underlying)
Award
Common Stock
2019-08-29+885→ 891 total
Disposition to Issuer
Class N Warrant (right to buy)
2019-05-01−885→ 0 total
Exercise: $0.00From: 2019-01-23Exp: 2019-05-01→ Common Stock (885 underlying)
Disposition to Issuer
Class N Warrant (right to buy)
2019-05-31−885→ 0 total
Exercise: $0.00From: 2019-05-01Exp: 2019-06-28→ Common Stock (885 underlying)
Exercise/Conversion
Class N Warrant (right to buy)
2019-08-29−885→ 0 total
Exercise: $0.00From: 2019-05-31Exp: 2019-09-03→ Common Stock (885 underlying)
Award
Common Stock
2019-08-29+1,141→ 2,032 total
Award
Class N Warrant (right to buy)
2017-12-21$0.00/sh+885$0→ 885 total
Exercise: $0.00From: 2017-12-21Exp: 2019-03-17→ Common Stock (885 underlying)
Award
Class N Warrant (right to buy)
2019-01-23+885→ 885 total
Exercise: $0.00From: 2019-01-23Exp: 2019-05-01→ Common Stock (885 underlying)
Award
Class N Warrant (right to buy)
2019-05-01+885→ 885 total
Exercise: $0.00From: 2019-05-01Exp: 2019-06-28→ Common Stock (885 underlying)
Award
Stock Option (right to buy)
2019-08-26+133→ 133 total
Exercise: $56.25Exp: 2029-08-26→ Common Stock (133 underlying)
Award
Class O Warrant (right to buy)
2017-12-11+1,141→ 1,141 total
Exercise: $0.00From: 2017-12-11Exp: 2019-03-17→ Common Stock (1,141 underlying)
Disposition to Issuer
Class O Warrant (right to buy)
2019-03-01−1,141→ 0 total
Exercise: $0.00From: 2017-12-11Exp: 2019-03-17→ Common Stock (1,141 underlying)
Disposition to Issuer
Class O Warrant (right to buy)
2019-05-31−1,141→ 0 total
Exercise: $0.00From: 2019-03-01Exp: 2019-06-28→ Common Stock (1,141 underlying)
Award
Class O Warrant (right to buy)
2019-03-01+1,141→ 1,141 total
Exercise: $0.00From: 2019-03-01Exp: 2019-06-28→ Common Stock (1,141 underlying)
Award
Class O Warrant (right to buy)
2019-05-31+1,141→ 1,141 total
Exercise: $0.00From: 2019-05-31Exp: 2019-09-03→ Common Stock (1,141 underlying)

Footnotes (10)

[F1]On August 29, 2019, the reporting person exercised the Class N Warrants for 885 shares of common stock of Sanuwave Health, Inc. (the "Company") at an exercise price of $0.00029 per share.
[F10]Options will vest over a period of three years in 12 equal installments on each quarterly anniversary of the grant date.
[F2]On August 29, 2019, the reporting person exercised the Class O Warrants for 1,141 shares of the Company's common stock at an exercise price of $0.00029 per share.
[F3]On January 23, 2019, the Company extended the expiration date of the Class N Warrants to May 1, 2019.
[F4]On May 1, 2019, the Company extended the expiration date of the Class N Warrants to June 28, 2019.
[F5]On May 31, 2019, the Company extended the expiration date of the Class N Warrants to September 3, 2019.
[F6]On December 11, 2017, the reporting person received Class O Warrants exercisable for 1,141 shares of common stock at an exercise price of $0.00029 per share as compensation.
[F7]On March 1, 2019, the Company extended the expiration date of the Class O Warrants to June 28, 2019.
[F8]On May 31, 2019, the Company extended the expiration date of the Class O Warrants to September 3, 2019.
[F9]Options were fully vested at the grant date.

Documents

1 file

4
rdgdoc.xmlPrimary
FORM 4